Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
Palisade Bio (PALI) Stock Price & Analysis
387 Followers
PALI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.74 - $76.50
Previous Close$2.73
Volume599.88K
Average Volume (3M)3.73M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$13.98M
Total Debt (Recent Filing)$692.00K
Price to Earnings (P/E)-0.1
Beta0.73
Next EarningsMar 17, 2023
EPS Estimate-$2.44
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-19.06
Shares Outstanding3,965,188
R-Squared0.09
Standard Deviation0.25
10 Day Avg. Volume1,424,498
30 Day Avg. Volume3,731,474
Price to Book (P/B)0.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusHold
Alpha-0.10
Number of Analyst Covering1
Palisade Bio News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PALI FAQ
What was Palisade Bio’s price range in the past 12 months?
Palisade Bio lowest stock price was $1.74 and its highest was $76.50 in the past 12 months.
What is Palisade Bio’s market cap?
Currently, no data Available
When is Palisade Bio’s upcoming earnings report date?
Palisade Bio’s upcoming earnings report date is Mar 17, 2023 which is in 38 days.
How were Palisade Bio’s earnings last quarter?
Palisade Bio released its earnings results on Nov 14, 2022. The company reported -$4 earnings per share for the quarter, the consensus estimate of -$4 by $0.
Is Palisade Bio overvalued?
According to Wall Street analysts Palisade Bio’s price is currently Overvalued.
Does Palisade Bio pay dividends?
Palisade Bio does not currently pay dividends.
What is Palisade Bio’s EPS estimate?
Palisade Bio’s EPS estimate is -$2.44.
How many shares outstanding does Palisade Bio have?
Palisade Bio has 3,965,188 shares outstanding.
What happened to Palisade Bio’s price movement after its last earnings report?
Palisade Bio reported an EPS of -$4 in its last earnings report, expectations of -$4. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Palisade Bio?
Currently, no hedge funds are holding shares in PALI
---
Palisade Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
―
―
Crowd Wisdom
Neutral
Last 7 Days ▲ 2.5%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Negative
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.81%
12-Months-Change
Fundamentals
Return on Equity
-115.80%
Trailing 12-Months
Asset Growth
-0.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Palisade Bio
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
---
Avenue Therapeutics
―
One World Pharma
―
Otonomy
―
Ampio Pharmaceuticals
―
Earth Science Tech
―
---